CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Grifols SA Company Snapshot
Grifols SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grifols SA with three other pharmaceutical manufacturers in Europe: Stada Arzneimittel AG of Germany (2016 sales of 2.15 billion Euro [US$2.32 billion] ), Lonza Group AG of Switzerland (4.13 billion Swiss Francs [US$4.17 billion] ), and UCB Sa which is based in Belgium (4.18 billion Euro [US$4.51 billion] of which 100% was Biopharmacy).

Sales Analysis. Grifols SA reported sales of 4.05 billion Euro (US$4.37 billion) for the year ending December of 2016. This represents an increase of 2.9% versus 2015, when the company's sales were 3.93 billion Euro. Sales at Grifols SA have increased during each of the previous five years (and since 2011, sales have increased a total of 126%). Sales of Bioscience saw an increase that was more than double the company's growth rate: sales were up 6.5% in 2016, from 3.03 billion Euro to 3.23 billion Euro. Not all segments of Grifols SA experienced an increase in sales in 2016: sales of Others/raw Materials fell 48.6% to 58.99 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales). Grifols SA also experienced decreases in sales in Diagnostics (down 4.0% to 663.98 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Grifols SA
  Stock Performance Chart for Grifols SA
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 22.15
(Figures in Euro)
1 Week 2.2%   13 Weeks 6.4%  
4 Weeks 18.6%   52 Weeks 13.7%  
 
Grifols SA Key Data:
  Ticker: GRF Country: Spain
  Exchanges: MAD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 4,049,830,000
(Year Ending Jan 2017).
Employees: 14,890
  Currency: Euro Market Cap: 15,124,555,432
  Fiscal Yr Ends: December Shares Outstanding: 682,824,173
  Share Type: Accion Closely Held Shares: 134,656,881
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.